TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 0
Operating Income -1.2M
Net Income -1.2M
EPS (Diluted) ₹-0.09

Balance Sheet Metrics

Total Assets 88.4M
Total Liabilities 3.0M
Shareholders Equity 85.3M
Debt to Equity 0.04

Cash Flow Metrics

Revenue & Profitability Trend

Genesis IBRC India Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i00000
Cost of Goods Sold i00000
Gross Profit i00000
Gross Margin % i0.0%0.0%0.0%0.0%0.0%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i152.0K172.0K101.0K73.0K115.0K
Other Operating Expenses i-35.7M37.4M696.0K670.0K627.0K
Total Operating Expenses i-35.6M37.6M797.0K743.0K742.0K
Operating Income i35.0M-38.0M-940.0K-1.2M-1.2M
Operating Margin % i0.0%0.0%0.0%0.0%0.0%
Non-Operating Items
Interest Income i-----
Interest Expense i03.0K04.0K0
Other Non-Operating Income-----
Pre-tax Income i35.0M-38.0M-1.4M-1.2M-1.2M
Income Tax i00000
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i35.0M-38.0M-1.4M-1.2M-1.2M
Net Margin % i0.0%0.0%0.0%0.0%0.0%
Key Metrics
EBITDA i35.0M-38.0M-940.0K-1.2M-1.2M
EPS (Basic) i₹2.70₹-2.92₹-0.11₹-0.09₹-0.09
EPS (Diluted) i₹2.70₹-2.92₹-0.11₹-0.09₹-0.09
Basic Shares Outstanding i1300000013000000130000001300000013000000
Diluted Shares Outstanding i1300000013000000130000001300000013000000

Income Statement Trend

Genesis IBRC India Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i57.0K60.0K71.0K138.0K89.0K
Short-term Investments i-----
Accounts Receivable i000434.0K434.0K
Inventory i-----
Other Current Assets51.6M52.0M-1.0K45.9M-1
Total Current Assets i88.4M52.1M89.7M90.9M92.0M
Non-Current Assets
Property, Plant & Equipment i-----
Goodwill i-----
Intangible Assets i-----
Long-term Investments-----
Other Non-Current Assets-----
Total Non-Current Assets i00000
Total Assets i88.4M52.1M89.7M90.9M92.0M
Liabilities
Current Liabilities
Accounts Payable i374.0K377.0K377.0K377.0K377.0K
Short-term Debt i-----
Current Portion of Long-term Debt-----
Other Current Liabilities1.9M1.3M990.0K938.0K751.0K
Total Current Liabilities i3.0M1.8M1.4M1.3M1.2M
Non-Current Liabilities
Long-term Debt i-----
Deferred Tax Liabilities i-0000
Other Non-Current Liabilities---1.0K--
Total Non-Current Liabilities i00-1.0K00
Total Liabilities i3.0M1.8M1.4M1.3M1.2M
Equity
Common Stock i130.0M130.0M130.0M130.0M130.0M
Retained Earnings i-83.1M-118.1M-80.1M-78.8M-77.6M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i85.3M50.3M88.3M89.6M90.8M
Key Metrics
Total Debt i00000
Working Capital i85.3M50.3M88.3M89.6M90.8M

Balance Sheet Composition

Genesis IBRC India Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i35.0M-38.0M-1.4M-1.2M-1.2M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-35.0M31.5M454.0K-10.0K-46.0K
Operating Cash Flow i0-6.5M-920.0K-1.2M-1.2M
Investing Activities
Capital Expenditures i-----
Acquisitions i-----
Investment Purchases i-0000
Investment Sales i-----
Investing Cash Flow i-0000
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i-----
Debt Repayment i-----
Financing Cash Flow i0----
Free Cash Flow i-3.0K-11.0K-920.0K-1.2M-1.2M
Net Change in Cash i0-6.5M-920.0K-1.2M-1.2M

Cash Flow Trend

Genesis IBRC India Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 29.47
Price to Book 10.23
Price to Sales 28.00
PEG Ratio 1.03

Profitability Ratios

Profit Margin 94.96%
Operating Margin 94.96%
Return on Equity 41.08%
Return on Assets 39.67%

Financial Health

Current Ratio 29.18
Debt to Equity 0.00
Beta 0.54

Per Share Data

EPS (TTM) ₹2.68
Book Value per Share ₹7.72
Revenue per Share ₹2.86

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
genesis1.0B29.4710.2341.08%94.96%0.00
Biocon 470.2B109.741.953.66%2.44%66.26
OneSource Specialty 214.4B-1,148.533.64-0.31%-0.85%16.03
Zota Health Care 46.7B-74.4719.30-24.83%-17.04%0.61
Dishman Carbogen 45.3B42.710.760.06%3.60%40.97
Panacea Biotec 26.3B222.063.03-1.01%1.88%2.67

Financial data is updated regularly. All figures are in the company's reporting currency.